Brief: Chugai: Files Lawsuit Against Alexion For Infringement Of Its Proprietary Antibody Engineering Technology In Japan
Dec 5 (Reuters) - Japan's Chugai Pharmaceutical Co Ltd
4519.T :
* FILES LAWSUIT AGAINST ALEXION FOR INFRINGEMENT OF ITS
PROPRIETARY ANTIBODY ENGINEERING TECHNOLOGY IN JAPAN
Source text for Eikon: urn:newsml:reuters.com:*:nTSXE6cb9e
Further company coverage: 4519.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)